Trials / Completed
CompletedNCT03260283
Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Saint Savvas Anticancer Hospital · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the efficacy of subarachnoid anesthesia with low dose of pethidine (0.4mgkg-1) compared to administration of ropivacaine and fentanyl which is nowadays the common practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pethidine hydrochloride | In Group I patients will be administered with low dose of pethidine hydrochloride (0.4 mgkg-1) diluted into normal saline up to 2 ml of total volume in order to perform subarachnoid anesthesia for urologic operations |
| DRUG | Ropivacaine HCl Inj 7.5 MG/ML | In Group II patients will be administered with 2 ml of ropivacaine (0.75%) |
| DRUG | Fentanyl | 15 mcg of fentanyl will be added to the solution in order to perform subarachnoid anesthesia for urologic operations |
Timeline
- Start date
- 2017-08-16
- Primary completion
- 2018-11-29
- Completion
- 2019-12-31
- First posted
- 2017-08-24
- Last updated
- 2020-03-31
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03260283. Inclusion in this directory is not an endorsement.